Steffen Uffenorde/LinkedIn
Sep 7, 2026, 16:27
Steffen Uffenorde: WHO Consolidated Guidelines for SCD in Children and Adolescents
Steffen Uffenorde, Head of Market Access and Health Economics, Europe and Middle East at Terumo Blood and Cell Technologies; University Lecturer for International HTA, Pricing and Reimbursement, Pharmacoeconomic Evaluation at Hochschule Fresenius, shared a post on LinkedIn:
“WHO consolidated guidelines for the management of Sickle Cell Disease in children and adolescents.
The guideline notes: ‘The choice between exchange and simple RBC transfusion should be guided by clinical urgency, local resource availability and the potential for improved outcomes with exchange transfusion’.”
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters
-
Oct 28, 2026, 13:13Michael Cahillane: Three-Buffy-Coat Platelets – Strengthening Blood Supply Resilience
-
Oct 28, 2026, 13:05N. Mariana S. Vasquez: Antiplatelets vs Anticoagulants – Key Clinical Differences
-
Oct 28, 2026, 12:45Panithaya Chareonthaitawee: A Podcast Walk Through Anticoagulation
-
Oct 28, 2026, 11:55Natalia C. Badillo: Anticoagulation in AF – A Decision Beyond the Score